Possible points of action in the future, representing a valuable adjunct in the treatment of post-burn neuropathy and, most possibly, booster nerve regeneration, could be picked up from the experimental animal studies, which aim to booster nerve regeneration by exogenous-applied substances such as Fujimucin, nerve growth factor, brain-derived nerve factor, recombinant human glial growth factor, nitric oxide and interleukin 1 beta [35,37,39,40,41,42,43], and/or utilizing fibroblast-enriched human skin grafts for more efficiently targeted nerve regrowth. The gene discussed is NRG1; the disease is neuropathy.